Gedeon Richter and Allergan Receive U.S. FDA Approval For Expanded Use of VRAYLAR (cariprazine) in the Treatment of Bipolar Depression
5/28/2019
Business related Regulatory Marketing authorization application granted Central Nervous System PARTNER - ALLERGAN / ABBVIE / ACTAVIS PRODUCT - VRAYLAR API - CARIPRAZINE